28th Sep 2006 07:01
Dechra Pharmaceuticals PLC28 September 2006 Issued by Citigate Dewe Rogerson Limited, BirminghamDate: Thursday 28th September 2006 Embargoed: 7.00am Dechra Pharmaceuticals PLC (the "Company" or the "Group") Annual Information Update The Report & Accounts for the year ended 30 June 2006 has been posted toshareholders. A copy of the Report and Accounts document has also been submitted to the UKListing Authority. Further copies are available on request from the CompanySecretary, Dechra Pharmaceuticals PLC, Dechra House, Jamage Industrial Estate,Talke Pits, Stoke-on-Trent, ST7 1XW or from the Group web-site (www.dechra.com). Under the new rules introduced on 1 July 2005 relating to Prospectus Directivesby the UKLA, companies are required to list all regulatory news announcementsissued by the Company in the twelve month period preceding the date that thepublished Accounts are issued to shareholders. Dechra Pharmaceuticals PLC would like to advise that the following RegulatoryNews Announcements have been issued by the Company over the period from 1October 2005 to 29 September 2006: 29 September 2006 Annual Information Update26 September 2006 Block Listing six monthly return25 September 2006 Director/PDMR Shareholding22 September 2006 Report & Accounts for the year ended 30 June 2006 Published21 September 2006 Holding(s) in Company19 September 2006 Director/PDMR Shareholding15 September 2006 Blocklisting Interim Review15 September 2006 Blocklisting Interim Review5 September 2006 Additional Listing5 September 2006 Final Results for the year ended 30 June 200621 August 2006 Notice of Results27 July 2006 Change of Adviser10 July 2006 Pre-Close Period Update5 July 2006 Director/PDMR Shareholding26 June 2006 Holding(s) in Company21 June 2006 Director/PDMR Shareholding12 June 2006 Holding(s) in Company2 June 2006 EGM Statement18 May 2006 Notice of EGM8 March 2006 Additional Listing28 February 2006 Interim Results for the six months ended 31 December 200524 February 2006 Holding(s) in Company21 February 2006 Holding(s) in Company20 January 2006 Holding(s) in Company9 January 2006 Trading Update19 October 2005 AGM Statement19 October 2005 Adoption of IFRS10 October 2005 Holding(s) in Company Further details on the information contained within the above RNS announcementscan be viewed on the London Stock Exchange website: www.londonstockexchange.comunder code: DPH. Enquiries:Steve WhitehouseCompany Secretary Dechra Pharmaceuticals PLCTel: +44 (0) 1782 771100 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
DPH.L